IMMUNOCYTOCHEMISTRY CNTN1, NF140, NF155 AND NF 186 IN CIDPRIT COHORT (20/02/2024)

AIM: to test for anti-CNTN1, NF140, NF 155 and NF186 antibodies in patients with CIDP (CIDPRIT cohort) at baseline.

MATERIALS REQUIRED:

  • Cells (cultured on coverslips or chamber slides)
  • Fixative (4% paraformaldehyde)
  • Blocking buffer (Rabbit serum 1/40 for CNTN1 and goat serum 5% for NF).
  • Primary antibody (anti-CNTN1 and anti-PanNF).
  • Secondary antibody conjugated to a fluorophore (RAG488 and RAH594 for CNTN1, GAC488 and GAH594 for NF).
  • Mounting medium (Fluoromont)
  • PBS (phosphate-buffered saline) 1x

SAMPLES: 5 Samples from the CIDPRIT CIDP cohort at baseline, 1 positive control for CNTN1, 1 positive control for NF 140/186, 1 positive control for NF155.

PREPARATION OF CELLS:

  • Grow transfected cells with the protein of interest (CNTN1, NF140, NF155, and NF186) on chamber slides.

FIXATION:

  • Fix cells with the fixative solution (4% paraformaldehyde) for 10 minutes at room temperature.
  • Rinse cells with PBS to remove fixative.

BLOCKING:

  • Block nonspecific binding sites by incubating cells in blocking buffer for 60 minutes.
  • Wash cells 3 times with PBS.

PRIMARY ANTIBODY INCUBATION:

  • Dilute the primary antibody in blocking buffer (1/500).
  • Incubate cells with the primary antibody solution for 1 hour at room temperature.
  • Wash cells 3 times with PBS to remove unbound primary antibody.

SECONDARY ANTIBODY INCUBATION:

  • Dilute the secondary antibody conjugated to a fluorophore in blocking buffer (1+1/500).
  • Incubate cells with the secondary antibody solution for 1 hour at room temperature in the dark.
  • Wash cells 3 times with PBS to remove unbound secondary antibody.

MOUNTING:

  • Mount coverslips on glass slides using mounting medium.

IMAGING:

  • Visualize cells using a fluorescence microscope equipped with appropriate filters for the fluorophores used.

RESULTS:

24-2-0222: negative

24-2-0224: negative

24-2-0229: negative

24-2-0232: negative

24-2-0235: negative

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.